Sudheer Jayaprabhu, MD
Obstetrics & Gynecology · Texarkana, TXNPI 1639176555
Payments from drug & device makers
Across 37 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$125
- Shield Therapeutics Inc$121
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$98
- Intuitive Surgical$76
- AbbVie$62
- Astellas Pharma US Inc$56
- plus $394 from 18 others
What the payments were for
- Food & beverage$931100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $125 |
| Shield Therapeutics Inc | 4 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $98 |
| Intuitive Surgical | 1 | $76 |
| AbbVie(2 entities) | 4 | $62 |
| Astellas Pharma US Inc | 3 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Conmed Corporation | 1 | $33 |
| Lupin Inc. | 2 | $33 |
| Agile Therapeutics, Inc. | 2 | $33 |
| Myovant Sciences Inc. | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Exeltis, USA Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| KCI USA, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $14 |
| Medtronic | 1 | $14 |
| Axonics, Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Sage Therapeutics, LLC | 1 | $12 |
| Channel Medsystems, Inc. | 1 | $7 |
| Organon | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$125
How this compares
$931 in reported general payments places this provider in the 50th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 126 | $4,007 |
| Drospirenone-Ethinyl EstradiolEthinyl Estradiol/Drospirenone | 12 | $403 |
| Fluconazole | 31 | $302 |
| Medroxyprogesterone Acetate | 13 | $278 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $88 |
| Doxycycline Hyclate | 11 | $57 |
| Ibuprofen | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Texarkana
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
- Dawnette PepplerArlington$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.